Debt to Equity Ratio Chart

View Debt to Equity Ratio for ARTL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Debt to Equity Ratio Chart
Start Trial

Historical Debt to Equity Ratio Data

View and export this data back to 2016. Start Trial.
Date Value
June 30, 2026 0.0098
March 31, 2026 0.1078
December 31, 2025 -0.533
September 30, 2025 -1.507
June 30, 2025 -0.6245
March 31, 2025 0.1457
December 31, 2024 0.0364
September 30, 2024 0.0176
June 30, 2024 0.0164
March 31, 2024 0.0133
December 31, 2023 0.002
September 30, 2023 0.0022
June 30, 2023 0.0025
March 31, 2023 0.0029
December 31, 2022 0.0032
September 30, 2022 0.0034
June 30, 2022 0.0036
March 31, 2022 0.0031
August 31, 2021 0.0079
Date Value
May 31, 2021 0.00
February 28, 2021 0.00
November 30, 2020 0.00
August 31, 2020 0.00
May 31, 2020 0.00
February 29, 2020 0.00
November 30, 2019 0.00
August 31, 2019 0.00
May 31, 2019 0.00
February 28, 2019 0.00
November 30, 2018 0.00
August 31, 2018 0.00
May 31, 2018 0.00
February 28, 2018 0.00
November 30, 2017 0.00
August 31, 2017 0.00
May 31, 2017 -0.2608
February 28, 2017 -1.518
November 30, 2016 0.00

Debt to Equity Ratio Definition

The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.

Read full definition.

Debt to Equity Ratio Range, Past 5 Years

View Debt to Equity Ratio Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Debt to Equity Ratio Benchmarks

View Debt to Equity Ratio Benchmarks
Start Trial
ANI Pharmaceuticals, Inc. 1.022
Corcept Therapeutics, Inc. 0.0133
Veru, Inc. 0.0945
Johnson & Johnson 0.5771
Eli Lilly & Co. 1.621